H. B. Fuller Company (NYSE:FUL) Stock Has Consensus Target Price of $64.62 According to Brokerages
H. B. Fuller Company (NYSE:FUL) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $64.62, significantly higher than its current share price of $50.28. Despite some recent target reductions by analysts, the company's latest quarterly earnings showed an EPS beat ($1.52 vs. $1.47 consensus) and a 5.2% revenue increase, though revenue slightly missed estimates. Insider purchases totaling approximately $621,000 in shares by directors suggest confidence in the stock's valuation.
A 1,300-unit stock grant goes to Fuller H B Co (FUL) director R. Jeffrey Bailly.
Fuller H B Co (FUL) director R. Jeffrey Bailly received an award of 1,300 restricted stock units (RSUs) on September 30, 2026. These RSUs convert into common stock on a 1-for-1 basis, bringing his direct RSU holdings to 1,300 units. The exercise and expiration date for these units is listed as September 30, 2029.
H. B. Fuller Company (NYSE:FUL) Shareholders to Get $0.24 Quarterly Dividend
H. B. Fuller Company announced a quarterly dividend of $0.245 per share, resulting in an annualized dividend of $0.98 and a 2.0% yield. This marks the company's 57th consecutive year of dividend increases, with the dividend being well-covered by earnings at a 21.2% payout ratio. The specialty chemicals company recently reported strong quarterly EPS of $1.52, beating estimates, and a 5.2% year-over-year revenue increase.
Director Michael Happe Buys 2,000 Shares of H.B. Fuller Co (FUL)
Michael Happe, a Director at H.B. Fuller Co (FUL), recently purchased 2,000 shares of the company for approximately $99,260, increasing his total holdings to 3,343 shares. This transaction, along with broader insider buying trends and the stock's "Modestly Undervalued" GF Value, suggests a positive outlook for the company. H.B. Fuller Co specializes in adhesives and specialty chemical products, serving diverse industries globally.
Board Member Of H.B. Fuller Makes $100K Buy
Srilata Zaheer, a Board Member at H.B. Fuller, recently purchased 2,040 shares of the company's stock for $100,118, indicating confidence in its future. The company, which manufactures adhesives and sealants, has faced revenue challenges and has a low gross margin but shows an attractive valuation based on its P/E, P/S, and EV/EBITDA ratios. This insider purchase suggests a positive outlook despite recent financial performance dips.
H. B. Fuller (NYSE:FUL) Director Michael Happe Buys 2,000 Shares of Stock
H. B. Fuller (NYSE:FUL) Director Michael Happe recently purchased 2,000 shares of the company's stock for $99,240, increasing his direct ownership by almost 149%. The company exceeded quarterly earnings estimates with an EPS of $1.52, though revenue of $938.2 million fell short of expectations. Analysts currently hold a "Moderate Buy" consensus for FUL, with an average price target of $64.62, and the company offers a $0.98 annualized dividend, yielding about 2%.
H. B. Fuller (NYSE:FUL) Director Srilata Zaheer Purchases 2,000 Shares of Company Stock
H. B. Fuller (NYSE:FUL) Director Srilata Zaheer recently purchased 2,000 shares of the company's stock for $98,120, increasing her direct ownership by 148.59%. She also bought an additional 40 shares. The company reported better-than-expected quarterly EPS of $1.52 and a 5.2% year-over-year revenue increase, with analysts maintaining a "Moderate Buy" rating and an average price target of $64.62.
H.B. Fuller director Thomas Handley buys $98,820 in stock
H.B. Fuller Co. director Thomas W. Handley recently purchased 2,000 shares of the company's stock for $98,820, with shares trading near their 52-week low. InvestingPro analysis suggests the stock is undervalued, and Handley holds additional shares and stock units. The company has a strong dividend track record and recently reported better-than-expected adjusted earnings but missed revenue forecasts, leading Baird to lower its price target.
H.B. Fuller director Charles Lauber purchases $99,984 of stock
H.B. Fuller director Charles T. Lauber recently purchased 2,005 shares of the company's common stock for a total of $99,984, with prices ranging from $49.7767 to $49.9400 per share. This transaction occurred as the stock is trading near its 52-week low and is considered undervalued by InvestingPro. Following the purchase, Mr. Lauber directly holds 3,356 shares, in addition to 13,169.88 stock units convertible upon specific events.
Ancora Holdings ups the ante for H.B. Fuller's building adhesives
Ancora Holdings Group has submitted an enhanced proposal to acquire H.B. Fuller's Building Adhesive Solutions segment for $1.2 billion to $1.4 billion in cash. This updated offer follows a rejected initial proposal and is backed by a "highly confident" letter from Fortress Investment Group for debt financing. Ancora aims to help H.B. Fuller address its elevated leverage and improve shareholder value by divesting the BAS segment.
Activist Ancora Comes Back With Bigger Bid For H.B. Fuller Unit
Activist investor Ancora Holdings Group has increased its offer to acquire H.B. Fuller Co.'s Building Adhesive Solutions business to between $1.2 billion and $1.4 billion, backed by financing from Fortress Investment Group. This revised proposal follows a previous offer of $1.1 billion to $1.2 billion, which H.B. Fuller rejected for undervaluing the unit. Ancora believes the sale would significantly reduce H.B. Fuller's debt and balance-sheet risk, while H.B. Fuller management, despite previously citing integration challenges, has shown increased openness to divestitures for deleveraging purposes.
Ancora Raises Offer for H.B. Fuller Unit to $1.4B
Ancora has increased its cash offer for H.B. Fuller's building adhesives business to a range of $1.2 billion to $1.4 billion, a $200 million raise on the upper end of its previous proposal. The firm has secured a "highly confident" letter from Fortress Investment Group for debt financing, which follows H.B. Fuller's earlier rejection of Ancora's lower bid as insufficient. This activist move comes as H.B. Fuller's shares have dropped about 17% this year, valuing the company at approximately $2.7 billion.
Ancora Raises Offer for H.B. Fuller Building Adhesives Business to $1.4 Billion
Ancora Holdings Group has increased its offer to acquire H.B. Fuller Co.'s Building Adhesive Solutions (BAS) business to between $1.2 billion and $1.4 billion, pressing the company for engagement. This revised bid, an increase from their previous $1.1-$1.2 billion offer, is supported by a "highly confident" letter for debt financing from Fortress Investment Group. Ancora argues the divestiture would help H.B. Fuller reduce debt and improve its capital structure, despite H.B. Fuller's previous rejection based on undervaluation and potential dis-synergies.
Activist Ancora submits higher offer for H.B. Fuller building unit
Activist investor Ancora Holdings has increased its offer for H.B. Fuller's building adhesives unit to between $1.2 billion and $1.4 billion. This updated bid comes after H.B. Fuller (FUL) previously rejected Ancora's initial offer last month. The offer aims to acquire the adhesives business of the chemicals company.
H.B. Fuller (FUL) Brings Medical Technology Experience To Its Board
H.B. Fuller (FUL) has appointed R. Jeffrey Bailly to its board, adding valuable medical technology and business transformation expertise. This move aligns with the company's focus on higher-margin healthcare exposure, though activist investor Ancora is simultaneously pressuring H.B. Fuller for a strategic review of alternatives and governance changes. Investors are urged to consider these board changes within the context of the company's broader margin-focused narrative and financial health.
Ancora raises bid for H.B. Fuller building unit to $1.4 billion, Bloomberg says
Activist investor Ancora Holdings Group has increased its unsolicited bid for H.B. Fuller Company's building adhesives unit to as much as $1.4 billion. The revised offer includes debt financing from Fortress Investment Group and aims to persuade H.B. Fuller's board to divest the lower-margin division, which Ancora believes would help reduce debt and improve management focus. H.B. Fuller had previously rejected a lower offer, stating it undervalued the division.
Ancora raises bid for H.B. Fuller building unit to $1.4 billion, Bloomberg says
Activist investor Ancora Holdings Group has increased its unsolicited offer for H.B. Fuller Company's building adhesives unit to $1.4 billion in cash, attempting to pressure the chemical maker's board after an initial rejection. The revised bid includes debt financing assurances and aims to persuade H.B. Fuller to divest the lower-margin division to pay down debt and focus on its acquisition of Advanced Medical Solutions. H.B. Fuller's board previously rejected a lower offer, citing undervaluation and lack of execution details.
Cleveland-based activist Ancora raises bid for H.B. Fuller building unit
Cleveland-based activist investor Ancora has increased its bid for H.B. Fuller's building unit. This development was reported by Mengqi Sun of Bloomberg. The article, published on September 29, 2026, details the ongoing efforts by Ancora regarding the H.B. Fuller Co.
H.B. Fuller Appoints R. Jeffrey Bailly to Board of Directors
H.B. Fuller has appointed R. Jeffrey Bailly to its Board of Directors, effective immediately, while Ruth Kimmelshue steps down. Bailly brings over three decades of executive leadership, particularly in transforming UFP Technologies and growing its medical technology focus. His appointment is expected to help H.B. Fuller accelerate its path to higher adjusted EBITDA margins and continue its strategic repositioning towards faster-growing, higher-margin end markets.
H.B. Fuller Appoints R. Jeffrey Bailly to Board of Directors
H.B. Fuller Company has appointed R. Jeffrey Bailly to its Board of Directors, effective immediately, bringing his extensive experience in business transformation, M&A, manufacturing, and medical technology. Bailly previously served as CEO of UFP Technologies, where he significantly grew the company's revenue and market capitalization by focusing on higher-growth medical end markets. Ruth Kimmelshue is stepping down from the Board, and the company expects Bailly's expertise to support its strategic shift towards faster-growing, higher-margin sectors and achieving its financial objectives.
H.B. Fuller Reports $938 Million In Q3 Revenue And $187 Million Adjusted EBITDA And Updates Full-Year Outlook
H.B. Fuller reported strong third-quarter 2026 results with $938 million in revenue, a 5.2% year-over-year increase, and adjusted EBITDA of $187 million, up 9%. The company's performance was driven by pricing improvements and operational efficiency initiatives, leading to an updated full-year adjusted EBITDA outlook of $655 million to $670 million. H.B. Fuller also highlighted its Quantum Leap transformation program and anticipated acquisition of AMS to further strengthen its portfolio and profitability.
Is H.B. Fuller (FUL) Stock a Bargain After Q3 Earnings?
H.B. Fuller's Q3 earnings showed a 5.2% revenue increase and a 21% surge in adjusted EPS, primarily driven by pricing power and cost discipline, not volume growth. The company is actively optimizing margins through manufacturing footprint reduction and aims for $75 million in annualized cost savings by 2030, raising its full-year guidance. However, declining customer demand for three consecutive quarters and concerns about balance sheet leverage post-acquisition of Advanced Medical Solutions/AMS raise questions about the sustainability of its top-line performance despite a seemingly cheap forward P/E of 9.44x.
H. B. Fuller Q3 Earnings Call Highlights
H. B. Fuller (FUL) reported strong Q3 fiscal 2026 results, with revenue increasing 5.2% and adjusted EBITDA up 9%, driven by effective pricing strategies and restructuring efforts despite lower volumes and high raw material costs. The company is progressing towards its Project Quantum Leap savings, aiming for $75 million in annualized conversion-cost savings by 2030, and maintained its fiscal 2026 outlook. Management also discussed the pending acquisition of Advanced Medical Solutions to strengthen its healthcare portfolio.
H.B. Fuller Releases Q3 2026 Financial Results
H.B. Fuller Company reported strong third-quarter 2026 financial results, exceeding Wall Street expectations with adjusted earnings of $1.52 per share on revenue of $938.2 million. The company saw organic revenue growth of 4.4% and an overall revenue increase of 5.2% year-over-year. Management provided full-year adjusted EPS guidance between $4.70 and $4.85, reflecting continued confidence in the adhesives market.
Why H.B. Fuller Stock Dipped on Thursday
H.B. Fuller's stock saw a slight dip on Thursday following its fiscal third-quarter earnings report. While the chemical company beat analyst estimates for adjusted net profit, it missed on net revenue expectations. The stock's performance was affected by concerns over earnings guidance and the mixed financial results, despite an increase in overall pricing offsetting a decline in sales volume.
H. B. Fuller (FUL) Beats Q3 Earnings and Revenue Estimates
H. B. Fuller (FUL) reported strong Q3 earnings of $1.52 per share, surpassing the Zacks Consensus Estimate of $1.45, and revenues of $938.18 million, beating expectations. Despite these positive results and outperforming EPS estimates for four consecutive quarters, the stock has underperformed the S&P 500 year-to-date, and currently holds a Zacks Rank #4 (Sell) due to unfavorable estimate revision trends. Investors are advised to consider management's commentary and the industry outlook for future performance.
H. B. Fuller (NYSE:FUL) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPS
H. B. Fuller (NYSE:FUL) announced quarterly earnings of $1.52 per share, surpassing analyst estimates by $0.05. The company updated its fiscal 2026 EPS guidance to $4.70–$4.85, but its stock fell 1.2% to $50.48 following the results. Analysts maintain a "Moderate Buy" consensus with an average price target of $67.86, though a VP recently sold 9,561 shares.
H. B. Fuller (NYSE:FUL) Releases FY 2026 Earnings Guidance
H. B. Fuller (NYSE:FUL) has released its FY 2026 earnings per share (EPS) guidance, projecting $4.70-$4.85, which is slightly below the analyst consensus of $4.85. The company did not provide a revenue outlook for FY 2026. Shares of H. B. Fuller traded down to $50.48, and the company also declared a quarterly dividend of $0.245.
Earnings Flash (FUL) H.B. Fuller Company Reports Q3 Revenue $938.2M, vs. FactSet Est of $945.6M
H.B. Fuller Company (FUL) reported its Q3 revenue at $938.2 million, which fell short of FactSet's estimated $945.6 million. The article highlights recent news related to the company, including the cancellation of Ancora Holdings Group's acquisition of H.B. Fuller's Building Adhesive Solutions segment and other offers for parts of its business.
H B Fuller earnings beat by $0.05, revenue fell short of estimates
H.B. Fuller (NYSE: FUL) reported third-quarter earnings per share of $1.52, surpassing analyst estimates by $0.05, while revenue of $938 million fell short of the consensus forecast. The company also provided full-year 2026 EPS guidance between $4.70 and $4.85. Despite the earnings beat, H.B. Fuller's stock has seen a decline of over 20% in the last three months and over 15% in the past year.
H.B. Fuller Reports Third Quarter 2026 Results
H.B. Fuller Company (NYSE: FUL) reported strong financial results for its third quarter ended August 29, 2026, with net revenue up 5.2% year-on-year to $938 million and adjusted EPS up 21% year-on-year to $1.52. The company achieved a record adjusted EBITDA margin of 19.9% and updated its fiscal 2026 outlook, expecting mid-single-digit net revenue growth and adjusted EBITDA between $655 million and $670 million. These results reflect disciplined execution, effective pricing strategies, and restructuring efforts, with the anticipated AMS acquisition further strengthening the company's portfolio.
H.B. Fuller Q3 EPS expected to rise 15.9% to $1.47 with revenue growth of 5.4%
H.B. Fuller is projected to report a significant increase in its Q3 earnings, with EPS expected to rise by 15.9% to $1.47 and revenue by 5.4% to $945.59 million. Despite a recent slight downgrade in EPS estimates, Citigroup maintains a bullish stance, raising its price target to $75. The company recently rejected an acquisition proposal, indicating confidence in its independent growth strategy, and the earnings report is scheduled for release after market close on September 23, 2026.
H.B. Fuller Q3 2026 Earnings Preview — September 24, Street Expects $1.46 EPS
Wall Street anticipates H.B. Fuller Company (FUL) will report solid year-over-year growth for its third-quarter fiscal 2026 results on September 24, with analysts expecting $1.46 EPS on $945.5 million in revenue. This forecast implies a 15.8% increase in EPS and 6.0% revenue growth compared to Q3 2025, driven by anticipated operating leverage and margin improvement. Investors will be watching gross margin trajectory and management commentary on raw material costs, pricing, and end-market demand.
H.B. Fuller Introduces Kōfinity™ Portfolio Featuring Fusion Bonded Spacers, Providing Maximum Performance in Window Seal Reliability
H.B. Fuller has launched Kōfinity™, a new product portfolio built on its proven 4SG technology, designed to enhance insulating glass (IG) solutions. Kōfinity™ features fusion bonded spacers that create a molecular bond with glass, eliminating common IG failure points and improving thermal performance. This innovation aims to address window seal failures, offering manufacturers operational efficiencies and providing durable, energy-efficient window solutions for homeowners.
H.B. Fuller launches Kōfinity insulating glass product line
H.B. Fuller has launched Kōfinity, a new product line for insulating glass solutions using its 4SG reactive thermoplastic spacer technology. This innovation aims to combat window seal failure, which leads to issues like fogging and reduced thermal performance. The Kōfinity system uses robotic precision to fusion bond spacers to glass, creating a continuous barrier and improving durability.
H.B. Fuller (FUL) Could Be 33% Undervalued Following Earnings Expectations
H.B. Fuller (FUL) is currently considered 33% undervalued, with a fair value estimated at $73.29 against its current price of $49.41. This assessment comes as Wall Street analysts anticipate quarterly earnings of $1.46 per share and revenues of $940.38 million for the August 2026 period. Despite recent share price declines, the company's focus on pricing discipline, especially in its HHC segment, is expected to positively impact revenue and EBITDA margins.
H.B. Fuller Co (FUL) Stock Price, Quote, News & History
This Benzinga article provides an overview of H.B. Fuller Co (FUL) stock, including its current price, key statistics, recent news, financial data, and analyst forecasts. The company is set to report Q3 2026 earnings soon, with expectations of higher EPS and revenue. Recent news highlights include Ancora's bid for its adhesives unit and an acquisition by Advanced Medical.
H. B. Fuller (NYSE:FUL) Hits New 52-Week Low - Here's What Happened
H. B. Fuller (NYSE:FUL) experienced a new 52-week low, trading at $48.60 despite strong analyst "Buy" ratings and a consensus price target of $67.86. The company recently reported better-than-expected quarterly earnings and revenue, along with a quarterly dividend. Insider selling by VP Nathan Weaver was also noted, reducing his stake significantly.
HB Fuller stock hits 52-week low at 48.6 USD
H.B. Fuller (FUL) stock has fallen to a 52-week low of $48.60, representing a 19.55% decrease over the past year. Despite this, InvestingPro data suggests the stock is undervalued, and the company has consistently raised its dividend for 33 consecutive years. Recent news also includes H.B. Fuller's rejection of a $1.2 billion acquisition bid for its Building Adhesive Solutions business and the announcement of a quarterly cash dividend of $0.245 per share.
Fuller Gains on Innovation Award
H.B. Fuller (NYSE: FUL) announced Bin Dasmal General Trading Co. and Huhtamaki as recipients of its 2026 Customer Innovation Award for their solutions in sustainability, safety, performance, and operational efficiency. The awards recognize customers for breakthroughs in areas like reducing plastic in food packaging and improving infrastructure durability, achieved through collaboration and technical expertise. FUL shares saw a gain of 46 cents, closing at $51.31.
H. B. Fuller (FUL) Projected to Post Quarterly Earnings on Wednesday
H. B. Fuller (FUL) is expected to report its Q3 2026 earnings on Wednesday, September 23rd, with analysts projecting earnings of $1.47 per share and revenue of $948.2 million. The company recently surpassed expectations in its last quarter, delivering $1.41 in adjusted EPS on $950.27 million in revenue. The stock currently has a "Buy" consensus rating and an average price target of $67.86.
H.B. Fuller to Report Third Quarter 2026 Results on September 23, 2026
H.B. Fuller Company (NYSE: FUL) will release its financial results for the three-month fiscal period ending August 29, 2026, after the market closes on September 23, 2026. The company will host an investor conference call on September 24, 2026, at 9:30 a.m. CT (10:30 a.m. ET) to discuss these results, with a live webcast available on their investor relations website. A telephone replay will also be available for a limited time after the call.
H. B. Fuller Company (NYSE:FUL) Receives Average Rating of "Buy" from Analysts
H. B. Fuller Company (NYSE:FUL) has received a consensus "Buy" rating from analysts, with an average 12-month price target of $67.86, significantly above its current share price of $53.10. The company recently surpassed quarterly earnings expectations, reporting $1.41 EPS against an estimated $1.37 and revenue of $950.27 million, a 5.8% increase year-over-year. Analysts anticipate a full-year EPS of $4.87, and the company also declared a quarterly dividend of $0.245 per share.
H.B. Fuller expands Gel-Tac™ microsphere technology production in Europe
H.B. Fuller is expanding its Gel-Tac™ microsphere adhesive production to its Pianezze facility in Italy, driven by market demand, customer proximity, and sustainability goals. This localization aims to improve supply responsiveness, reduce the carbon footprint by minimizing transatlantic shipments, and enable closer collaboration with European customers. The company is also developing next-generation Gel-Tac™ technologies to meet evolving market needs for enhanced adhesion on challenging substrates while maintaining repositionability and removability.
H.B. Fuller (FUL) Tells Ancora its $1.2 Billion Offer isn’t Enough
H.B. Fuller has rejected Ancora Holdings Group's $1.1-$1.2 billion offer for its Building Adhesives Solutions (BAS) business, stating the offer significantly undervalues the unit and ignores its growth prospects. The company also cited potential "dis-synergies" from a carve-out due to shared manufacturing operations. Despite the rejection, Ancora may continue its campaign, putting pressure on H.B. Fuller to demonstrate BAS's value through stronger earnings and execution of its broader strategy.
Bank of New York Mellon Corp Purchases Shares of 508,002 H. B. Fuller Company $FUL
Bank of New York Mellon Corp acquired 508,002 shares of H. B. Fuller Company (NYSE:FUL) for approximately $29.6 million, representing 0.94% of the specialty chemicals company. This acquisition contributes to the 95.93% institutional ownership of H. B. Fuller stock. The company has demonstrated strong financial performance, exceeding quarterly earnings and revenue expectations, and maintains a "Buy" rating from analysts with an average price target of $67.86.
Understanding the Setup: (FUL) and Scalable Risk
This article analyzes H. B. Fuller Company (FUL) with a focus on its near, mid, and long-term sentiment and risk-reward setup. It highlights a weak near and mid-term sentiment that could pressure a neutral long-term outlook, with an exceptional 34.4:1 risk-reward setup targeting a 10.1% gain versus 0.3% risk. The piece also outlines specific institutional trading strategies tailored for different risk profiles, including position, momentum breakout, and risk hedging strategies.
Zacks Research Upgrades H. B. Fuller (NYSE:FUL) to "Strong-Buy"
Zacks Research has upgraded H. B. Fuller (NYSE:FUL) from a "hold" to a "strong-buy" rating. This upgrade follows the company exceeding quarterly expectations with $1.41 EPS and $950.27 million in revenue, a 5.8% increase year-over-year. The article also notes ongoing strategic disputes with activist investor Ancora regarding a $1.2 billion proposal for H. B. Fuller’s BAS segment, which the company's board has rejected.
Ancora Reaffirms Bid for H.B. Fuller’s Building Adhesive Solutions Business
Ancora Holdings Group has reiterated its offer to acquire H.B. Fuller Company’s (NYSE: FUL) Building Adhesive Solutions segment, criticizing the company's board for rejecting the proposal without proper engagement. Ancora, a significant shareholder, believes this acquisition would help H.B. Fuller reduce leverage and unlock shareholder value, and is willing to increase its offer pending due diligence. The investment firm also challenged H.B. Fuller's current debt reduction strategy and called for leadership changes or a strategic review, indicating potential escalation of its campaign.
H.B. Fuller rejects Ancora proposal for Building Adhesives Solutions
H.B. Fuller Co.'s board of directors has unanimously rejected an unsolicited proposal from investment firm Ancora Holdings Group. The proposal aimed to acquire H.B. Fuller's Building Adhesives Solutions business. The company saw full-year net sales of approximately $3.47 billion in 2025.
